CrowdStrike [CRWD]
As of 2026-07-29 · spot $179.50 (post 4-for-1 split) · This memo issues no position verdict. The Valuation Criteria returns FAIL at −19.2pp, so nothing below is a case for owning it.
This is the first cluster tonight in which an options vehicle is actually available. Nine of the ten names where the chain was pulled before this cluster could not be filled at any size:
| Name | Chain depth found | Verdict |
|---|---|---|
| GMED | 13 contracts | Uninvestable |
| HCA | 18 — maximum open interest across an entire March-2027 expiry | Uninvestable |
| CRDO | 78 | Uninvestable |
| ISSC | 506 | Uninvestable |
| KNSA | 2,598 total across the chain | Marginal |
| CRWD | 5,883 at a single strike, 96 contracts — the widest ladder of the five | Investable |
| WDAY / CRM / ADBE / PANW | 6,771 / 4,229 / 3,356 / 2,713 at a single strike | Investable |
CRWD has the widest strike ladder of the five (96 contracts in the scanned window) and the second-deepest single strike (5,883). Note this is a post-split chain that has only existed since 2026-07-02 — four weeks — and it has already accumulated more open interest than HCA's entire March-2027 expiry by a factor of 327. That is a useful datapoint on how fast liquidity forms in a large-cap name versus a small one.
| Metric | Value | Basis |
|---|---|---|
| 3-month average daily volume | 12,037,632 shares | 62 sessions to 2026-07-28, split-adjusted |
| 3-month average daily value | $2,161m | VWAP-weighted |
| 252-day volatility | 47.6% | second-highest of the five |
| Option-implied volatility, Dec-26 | ~61% | §3 |
Sizing implication. At 20% of ADV, ~$432m can be transacted in a session. Liquidity constrains nothing.
Realised 47.6% against implied ~61% — a ~13 point premium, consistent with the rest of this cluster. Options are rich against realised movement here as elsewhere.
A split-mechanics note for the book. The 4-for-1 split on 2026-07-02 quadrupled the share count and quartered the price, so share-denominated position limits and ADV thresholds carried over from before 2026-07-02 are understated by 4x in share terms and unchanged in dollar terms. Any pre-July sizing rule expressed in shares needs re-basing. This is operational rather than analytical, and it is exactly the mismatch that produced the screen's $137bn market-cap error.
Liquidity Criteria: PASS.
Scanned: calls, expiry 2026-11-01 to 2027-02-28, strikes $153–$224 (0.85× to 1.25× spot). 96 contracts returned — the widest ladder of the five. Snapshots are live quotes and Greeks from the Alpaca options entitlement.
| Contract | Expiry | Strike | Open interest | Bid | Ask | Spread | Bid size | Ask size | IV | Delta |
|---|---|---|---|---|---|---|---|---|---|---|
| CRWD270115C00175000 | 2027-01-15 | 175 | 5,883 | — | — | — | — | — | — | — |
| CRWD270115C00165000 | 2027-01-15 | 165 | 3,243 | — | — | — | — | — | — | — |
| CRWD270115C00200000 | 2027-01-15 | 200 | 2,885 | — | — | — | — | — | — | — |
| CRWD261218C00200000 | 2026-12-18 | 200 | 2,810 | — | — | — | — | — | — | — |
| CRWD261218C00162500 | 2026-12-18 | 162.5 | 2,669 | — | — | — | — | — | — | — |
| CRWD261218C00165000 | 2026-12-18 | 165 | 2,596 | 35.74 | 37.85 | 5.6% | 39 | 156 | 61.4% | 0.685 |
Reference contract with a live quote: CRWD261218C00165000 — 2,596 open interest, a 5.6% bid/ask (the second tightest reference quote in the cluster after CRM's 4.4%), 39×156 quoted size, delta 0.685. At the $37.85 offer that is ~$590k of immediately available offer.
An honest limitation of this pull. The Alpaca snapshot returned a live quote for only one of the six highest-open-interest contracts; the other five returned open interest but no quote in the response. I therefore cannot assert bid/ask or quoted size for the 5,883-contract Jan-27 $175 strike, which is the deepest position on the chain. Open interest establishes that positions exist and can be closed; it does not establish today's tradeable spread. I report what was returned and decline to infer the rest — the HCA precedent is that assuming depth without pulling it is how an uninvestable vehicle gets proposed.
Structures that are actually fillable, on the evidence returned: - Dec-18-2026 $165 call — the only contract with a verified live quote: 2,596 OI, 5.6% spread, delta 0.685. It spans the Q2 FY27 print (~late Aug) and the Q3 print (~early Dec). - Jan-27 $175 call — 5,883 OI, the deepest position on the chain, quote unverified in this pull. Would require a fresh snapshot before sizing. - Cash equity — $2,161m ADV, 47.6% realised vol against ~61% implied.
Boundaries of the pull: strikes outside $153–$224 and expiries outside Nov-2026 to Feb-2027 were not scanned. Puts were not pulled — long-only book, no hedge proposed, and no downside structure is proposed on unpulled data.
The Valuation Criteria returns FAIL at −19.2pp on the identified sales-basis anchor, and it fails at every terminal margin from 10% to 35%. On a long-only book there is no position here and the memo does not construct one.
But the reason for the FAIL should not be mistaken for a judgement on the business, and this is the one name in the cluster where that distinction most needs making. CrowdStrike is, on the operating evidence:
It fails on price, not on quality. The Quality Criteria is scored PASS here, correcting a screen FAIL that came from measuring the margin change over the July-19 damage year rather than the run-rate (Research §10).
Short Mechanism Criteria: NOT triggered. Leg 1 fails outright — growth is accelerating, not decelerating. Whatever else is true of CRWD, it is not a short-mechanism candidate, and this is recorded to distinguish it from PANW, where both legs triggered.
What would have to change before a long could be constructed: the multiple, principally. At the five-year median of 25.48x EV/sales — a 29% de-rating from today — the required CAGR falls to roughly 30% and the margin to about −4.5pp, which is close to the noise band. CRWD becomes an interesting name on a meaningful de-rating and it is not one at 35.1x. The operational bull-side triggers (net new ARR delivering 27.7%, DBNRR above 118%, GAAP operating income positive without the commission-change benefit, SBC below 20% of revenue) would each help, but they do not close a 19pp gap on their own.
Momentum is strong and it does not change the answer. CRWD is +258% over five years, re-rated 59% in two quarters, and moved +12.1% in a single session on 2026-07-14. Momentum Criteria is MEASURED: it governs when to enter a position the thesis already justifies — never whether. Here the thesis does not justify one.
Invalidation of the FAIL — i.e. what would make me wrong. Stated because a FAIL deserves falsification tests as much as a PASS does: 1. Revenue growth sustaining above 30% for three consecutive quarters. The required path is 44.8% for five years; sustained 30%+ would make the gap bridgeable rather than structural. 2. DBNRR returning above 120% (next disclosed ~Mar 2027). At 115% the expansion motion is good; at 120%+ the compounding maths changes materially. 3. SBC falling below 18% of revenue while growth holds. That would convert the ex-SBC 16.7% operating margin into a GAAP margin fast enough to change the terminal-margin range. 4. The share count actually falling. Buyback coverage is 0.59x of SBC and the count rose 0.46% in Q1 FY27 alone; a genuine reduction would be a policy change, not a continuation.
What does not constitute invalidation: - A GAAP profit in any single quarter. Q1 FY27's $27.8m was smaller than the $27.9m contributed by the commission-amortisation change, and it also required $36.4m of realized investment gains and a tax benefit (Research §5a–b). A GAAP profit is only informative once it survives those adjustments. - Another AI partnership announcement. OpenAI, Anthropic, AWS, NVIDIA and Intel are all already named, and none of it carries a revenue figure. Per the brief, unquantified AI upside gets no credit. - Net new ARR beating a quarterly guide. The FY27 guide of +27.7% is the number that matters; a single quarter is noise in a metric this seasonal (Q1 is CRWD's weakest bookings quarter).